By Kat Greene ( May 31, 2017, 11:13 PM EDT) -- The Fifth Circuit on Wednesday refused to revive a $219 million False Claims Act suit by a would-be whistleblower accusing Abbott Laboratories of improperly marketing bile duct stents for veins, ruling the district court had correctly dismissed some claims and rejected a new trial....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.